Answer
Combining catridecacog (NovoThirteen) with recombinant activated factor VII (rFVIIa) is not recommended, based on a non-clinical study.
Sources for this answer
- NovoThirteen 2500 IU powder and solvent for solution for injectionNovo Nordisk Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked